{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T12:43:30Z","timestamp":1790081010382,"version":"4.0.1"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,5,31]],"date-time":"2017-05-31T00:00:00Z","timestamp":1496188800000},"content-version":"am","delay-in-days":303,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"publisher","award":["310030_152638"],"award-info":[{"award-number":["310030_152638"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.cyto.2016.05.012","type":"journal-article","created":{"date-parts":[[2016,5,31]],"date-time":"2016-05-31T18:16:49Z","timestamp":1464718609000},"page":"88-98","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":80,"special_numbering":"C","title":["Interleukin-36 potently stimulates human M2 macrophages, Langerhans cells and keratinocytes to produce pro-inflammatory cytokines"],"prefix":"10.1016","volume":"84","author":[{"given":"Damien","family":"Dietrich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Praxedis","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Flacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Jarrossay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolo","family":"Brembilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather A.","family":"Arnett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaby","family":"Palmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Towne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cem","family":"Gabay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2016.05.012_b0005","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.celrep.2015.12.072","article-title":"Neutrophil-derived proteases escalate inflammation through activation of IL-36 family cytokines","volume":"14","author":"Henry","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.cyto.2016.05.012_b0010","doi-asserted-by":"crossref","first-page":"42594","DOI":"10.1074\/jbc.M111.267922","article-title":"Interleukin-36 (IL-36) ligands require processing for full agonist (IL-36alpha, IL-36beta, and IL-36gamma) or antagonist (IL-36Ra) activity","volume":"286","author":"Towne","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cyto.2016.05.012_b0015","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.immuni.2013.11.010","article-title":"The interleukin-1 family: back to the future","volume":"39","author":"Garlanda","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.cyto.2016.05.012_b0020","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/nri2691","article-title":"The IL-1 family: regulators of immunity","volume":"10","author":"Sims","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cyto.2016.05.012_b0025","doi-asserted-by":"crossref","first-page":"13677","DOI":"10.1074\/jbc.M400117200","article-title":"Interleukin (IL)-1F6, IL-1F8, and IL-1F9 signal through IL-1Rrp2 and IL-1RAcP to activate the pathway leading to NF-kappaB and MAPKs","volume":"279","author":"Towne","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cyto.2016.05.012_b0030","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.4049\/jimmunol.167.3.1440","article-title":"Two novel IL-1 family members, IL-1 delta and IL-1 epsilon, function as an antagonist and agonist of NF-kappa B activation through the orphan IL-1 receptor-related protein 2","volume":"167","author":"Debets","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2016.05.012_b0035","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1126\/science.2969618","article-title":"cDNA expression cloning of the IL-1 receptor, a member of the immunoglobulin superfamily","volume":"241","author":"Sims","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.cyto.2016.05.012_b0040","doi-asserted-by":"crossref","first-page":"3868","DOI":"10.4049\/jimmunol.134.6.3868","article-title":"Effects of immune complexes on production by human monocytes of interleukin 1 or an interleukin 1 inhibitor","volume":"134","author":"Arend","year":"1985","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2016.05.012_b0045","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1172\/JCI112669","article-title":"Prostaglandin E2 and collagenase production by fibroblasts and synovial cells is regulated by urine-derived human interleukin 1 and inhibitor(s)","volume":"78","author":"Balavoine","year":"1986","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cyto.2016.05.012_b0050","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1056\/NEJMoa1013068","article-title":"Interleukin-36-receptor antagonist deficiency and generalized pustular psoriasis","volume":"365","author":"Marrakchi","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cyto.2016.05.012_b0055","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.ajhg.2011.07.022","article-title":"Mutations in IL36RN\/IL1F5 are associated with the severe episodic inflammatory skin disease known as generalized pustular psoriasis","volume":"89","author":"Onoufriadis","year":"2011","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.cyto.2016.05.012_b0060","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/humu.22203","article-title":"Mutation analysis of the IL36RN gene in 14 Japanese patients with generalized pustular psoriasis","volume":"34","author":"Farooq","year":"2013","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.cyto.2016.05.012_b0065","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1038\/jid.2013.230","article-title":"The majority of generalized pustular psoriasis without psoriasis vulgaris is caused by deficiency of interleukin-36 receptor antagonist","volume":"133","author":"Sugiura","year":"2013","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.cyto.2016.05.012_b0070","doi-asserted-by":"crossref","first-page":"e1043","DOI":"10.1542\/peds.2012-3935","article-title":"First clinical description of an infant with interleukin-36-receptor antagonist deficiency successfully treated with anakinra","volume":"132","author":"Rossi-Semerano","year":"2013","journal-title":"Pediatrics"},{"key":"10.1016\/j.cyto.2016.05.012_b0075","doi-asserted-by":"crossref","first-page":"3965","DOI":"10.1172\/JCI63451","article-title":"Psoriasiform dermatitis is driven by IL-36-mediated DC-keratinocyte crosstalk","volume":"122","author":"Tortola","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cyto.2016.05.012_b0080","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1056\/NEJMoa0809568","article-title":"An autoinflammatory disease due to homozygous deletion of the IL1RN locus","volume":"360","author":"Reddy","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cyto.2016.05.012_b0085","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1056\/NEJMoa0807865","article-title":"An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist","volume":"360","author":"Aksentijevich","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cyto.2016.05.012_b0090","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.cyto.2015.06.017","article-title":"The interleukin (IL)-1 cytokine family \u2013 balance between agonists and antagonists in inflammatory diseases","volume":"76","author":"Palomo","year":"2015","journal-title":"Cytokine"},{"key":"10.1016\/j.cyto.2016.05.012_b0095","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/nrrheum.2010.4","article-title":"IL-1 pathways in inflammation and human diseases","volume":"6","author":"Gabay","year":"2010","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.cyto.2016.05.012_b0100","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1189\/jlb.3RI1014-495R","article-title":"Regulation and function of interleukin-36 cytokines in homeostasis and pathological conditions","volume":"97","author":"Gabay","year":"2015","journal-title":"J. Leukocyte Biol."},{"key":"10.1016\/j.cyto.2016.05.012_b0105","doi-asserted-by":"crossref","first-page":"41684","DOI":"10.1074\/jbc.M112.385443","article-title":"IL-36gamma\/IL-1F9, an innate T-bet target in myeloid cells","volume":"287","author":"Bachmann","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cyto.2016.05.012_b0110","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.bbagrm.2015.06.002","article-title":"C\/EBPbeta is a transcriptional key regulator of IL-36alpha in murine macrophages","volume":"1849","author":"Nerlich","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.cyto.2016.05.012_b0115","doi-asserted-by":"crossref","first-page":"5813","DOI":"10.1182\/blood-2011-05-356873","article-title":"IL-36R ligands are potent regulators of dendritic and T cells","volume":"118","author":"Vigne","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.cyto.2016.05.012_b0120","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1182\/blood-2012-06-439026","article-title":"IL-36 signaling amplifies Th1 responses by enhancing proliferation and Th1 polarization of naive CD4+ T cells","volume":"120","author":"Vigne","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.cyto.2016.05.012_b0125","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/eji.201142035","article-title":"Expression of IL-1Rrp2 by human myelomonocytic cells is unique to DCs and facilitates DC maturation by IL-1F8 and IL-1F9","volume":"42","author":"Mutamba","year":"2012","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.cyto.2016.05.012_b0130","doi-asserted-by":"crossref","first-page":"6053","DOI":"10.4049\/jimmunol.1301481","article-title":"IL-36 promotes myeloid cell infiltration, activation, and inflammatory activity in skin","volume":"192","author":"Foster","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2016.05.012_b0135","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1136\/annrheumdis-2012-202264","article-title":"The novel cytokine interleukin-36alpha is expressed in psoriatic and rheumatoid arthritis synovium","volume":"72","author":"Frey","year":"2013","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.cyto.2016.05.012_b0140","doi-asserted-by":"crossref","first-page":"R80","DOI":"10.1186\/ar1946","article-title":"The new IL-1 family member IL-1F8 stimulates production of inflammatory mediators by synovial fibroblasts and articular chondrocytes","volume":"8","author":"Magne","year":"2006","journal-title":"Arthrit. Res. Ther."},{"key":"10.1016\/j.cyto.2016.05.012_b0145","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1038\/jid.2011.234","article-title":"Inter-regulation of Th17 cytokines and the IL-36 cytokines in vitro and in vivo: implications in psoriasis pathogenesis","volume":"131","author":"Carrier","year":"2011","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.cyto.2016.05.012_b0150","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1038\/jid.2011.482","article-title":"The double-stranded RNA analogue polyinosinic-polycytidylic acid induces keratinocyte pyroptosis and release of IL-36gamma","volume":"132","author":"Lian","year":"2012","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.cyto.2016.05.012_b0155","doi-asserted-by":"crossref","first-page":"e0126058","DOI":"10.1371\/journal.pone.0126058","article-title":"Limited contribution of IL-36 versus IL-1 and TNF pathways in host response to mycobacterial infection","volume":"10","author":"Segueni","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.cyto.2016.05.012_b0160","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/s12974-015-0392-7","article-title":"Interleukin-36gamma is expressed by neutrophils and can activate microglia, but has no role in experimental autoimmune encephalomyelitis","volume":"12","author":"Bozoyan","year":"2015","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.cyto.2016.05.012_b0165","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1182\/blood.V100.8.2858","article-title":"Myeloid blood CD11c(+) dendritic cells and monocyte-derived dendritic cells differ in their ability to stimulate T lymphocytes","volume":"100","author":"Osugi","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.cyto.2016.05.012_b0170","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.4049\/jimmunol.1003162","article-title":"IL-1F5, -F6, -F8, and -F9: a novel IL-1 family signaling system that is active in psoriasis and promotes keratinocyte antimicrobial peptide expression","volume":"186","author":"Johnston","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2016.05.012_b0175","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1172\/JCI32282","article-title":"Normal human dermis contains distinct populations of CD11c+BDCA-1+ dendritic cells and CD163+FXIIIA+ macrophages","volume":"117","author":"Zaba","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cyto.2016.05.012_b0180","doi-asserted-by":"crossref","first-page":"5730","DOI":"10.4049\/jimmunol.176.10.5730","article-title":"Cutting edge: CD1a+ antigen-presenting cells in human dermis respond rapidly to CCR7 ligands","volume":"176","author":"Angel","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2016.05.012_b0185","doi-asserted-by":"crossref","first-page":"6535","DOI":"10.4049\/jimmunol.151.11.6535","article-title":"Characterization of dermal dendritic cells obtained from normal human skin reveals phenotypic and functionally distinctive subsets","volume":"151","author":"Nestle","year":"1993","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2016.05.012_b0190","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/nrrheum.2014.156","article-title":"Inflammation: IL-36 has proinflammatory effects in skin but not in joints","volume":"10","author":"Dietrich","year":"2014","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.cyto.2016.05.012_b0195","doi-asserted-by":"crossref","first-page":"4354","DOI":"10.4049\/jimmunol.1000313","article-title":"IL-1RL2 and its ligands contribute to the cytokine network in psoriasis","volume":"185","author":"Blumberg","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2016.05.012_b0200","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1084\/jem.20070157","article-title":"Opposing activities of two novel members of the IL-1 ligand family regulate skin inflammation","volume":"204","author":"Blumberg","year":"2007","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cyto.2016.05.012_b0205","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1038\/jid.2015.289","article-title":"Unprocessed interleukin-36alpha regulates psoriasis-like skin inflammation in cooperation with interleukin-1","volume":"135","author":"Milora","year":"2015","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.cyto.2016.05.012_b0210","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1097\/MIB.0000000000000198","article-title":"IL-36gamma sustains a proinflammatory self-amplifying loop with IL-17C in anti-TNF-induced psoriasiform skin lesions of patients with Crohn\u2019s disease","volume":"20","author":"Friedrich","year":"2014","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.cyto.2016.05.012_b0215","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.4049\/jimmunol.0803463","article-title":"Alternatively activated macrophages elicited by helminth infection can be reprogrammed to enable microbial killing","volume":"182","author":"Mylonas","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2016.05.012_b0220","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/ijc.24401","article-title":"Interferon-gamma reverses the immunosuppressive and protumoral properties and prevents the generation of human tumor-associated macrophages","volume":"125","author":"Duluc","year":"2009","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.cyto.2016.05.012_b0225","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.1158\/0008-5472.CAN-04-4262","article-title":"Redirecting in vivo elicited tumor infiltrating macrophages and dendritic cells towards tumor rejection","volume":"65","author":"Guiducci","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.cyto.2016.05.012_b0230","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1365-2249.2005.02934.x","article-title":"Macrophage activation switching: an asset for the resolution of inflammation","volume":"142","author":"Porcheray","year":"2005","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.cyto.2016.05.012_b0235","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1172\/JCI59643","article-title":"Macrophage plasticity and polarization: in vivo veritas","volume":"122","author":"Sica","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cyto.2016.05.012_b0240","doi-asserted-by":"crossref","first-page":"R38","DOI":"10.1186\/ar4192","article-title":"The severity of experimental arthritis is independent of IL-36 receptor signaling","volume":"15","author":"Lamacchia","year":"2013","journal-title":"Arthrit. Res. Ther."}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466616300965?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466616300965?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T20:49:44Z","timestamp":1760906984000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466616300965"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":48,"alternative-id":["S1043466616300965"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2016.05.012","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interleukin-36 potently stimulates human M2 macrophages, Langerhans cells and keratinocytes to produce pro-inflammatory cytokines","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2016.05.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}